When homeostasis was disrupted, the overexpression of LRIG2, however, resulted in increased inflammation, angiogenesis, tumor progression, and an early onset of cSCC, which affected the ERBB signaling and components of the extracellular matrix (ECM). Here, LRIG2 is linked to neoplasm.